Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH

Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials

(2014) N. van Es et al.   BLOOD

Non-Vitamin K Antagonist Oral Anticoagulants

(2014) Gregory Y.H Lip et al.   CHEST

Atrial fibrillation, valvular heart disease, and use of target-specific oral anticoagulants for stroke prevention

(2014) S. H. Hohnloser et al.   EUROPEAN HEART JOURNAL

Direct Oral Anticoagulants (DOACs) Versus “New” Oral Anticoagulants (NOACs)?

(2014) Lars M. Asmis   SEMINARS IN HEMATOLOGY

Comment on: Editorial by Husted et al. “Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel”

(2014) Mark Crowther et al.   THROMBOSIS AND HAEMOSTASIS

Response to Ansell et al. “Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel”

(2014) Gregory Lip et al.   THROMBOSIS AND HAEMOSTASIS

Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel

(2014) Raffaele de Caterina et al.   THROMBOSIS AND HAEMOSTASIS

Direct Oral Anticoagulants for Acute Venous Thromboembolism

(2013) Peter Verhamme et al.   CIRCULATION

Measuring oral direct inhibitors of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis

(2013) T. Baglin et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS